Argá Medtech SA

Argá Medtech SA is a medical technology company based in San Diego, California, with an additional presence in Le Mont Pèlerin, Switzerland. The company specializes in developing advanced cardiac ablation systems, particularly targeting the treatment of cardiac arrhythmias like Atrial Fibrillation (AF). With approximately $58.5 million in venture capital funding, Argá Medtech is focused on innovating beyond traditional ablation methods through its novel Pulsed Field Ablation (PFA) system. The PFA system utilizes non-thermal energy to selectively ablate cardiac tissue, aiming to reduce collateral damage to surrounding areas, which is a common issue with existing methods such as Radio Frequency and Cryoablation. Argá Medtech's proprietary catheter enhances the precision and versatility of this technology, ultimately seeking to improve long-term outcomes for patients with AF. The company serves healthcare professionals, including cardiologists and electrophysiologists, as well as patients requiring interventional therapy for heart rhythm disorders.

• Employees 32
• Founded 2020
• Annual Revenue $2000000
• Total Funding $58523580